Business · Companies · 1 hr ago

Weight-loss drugs prompt Australia’s food industry to rethink meals

Weight-loss drugs prompt Australia’s food industry to rethink meals

Australia has approved two weight-loss pills as use of GLP-1 medicines grows.

The pills are Eli Lilly’s Foundayo and Novo Nordisk’s Wegovy, following a market that so far has mainly offered weekly injections.

These medicines reduce appetite and weight, and their growing use could affect a country where 67 per cent of adults are overweight or obese.

But users may face nutritional deficiencies and muscle loss, and experts warn that eating too little without professional guidance can raise the risk of malnutrition.

Australia’s food and grocery businesses are responding to a potential market of 7 million users within a decade, an estimate cited in the story.

They are considering smaller meals with more protein and fibre, while restaurants may offer smaller entrees and larger plates of meat to share.

The Wegovy pill is due to go on sale on Friday, while Foundayo is expected to be available in the coming days.

1 source

Related

What people are saying

Karen MartiniRestaurateur and cookbook author
Every chef wants to please the diner and see flavours savoured, and clean plates sent back to the kitchen.
via SMH
Dr Fiona WillerDietitians Australia president
You get full on much less food than before, so every mouthful counts when you’re on these drugs.
via SMH
Ben WilleeSpinach Advertising representative
I suspect we may look back on their impact on society and say it’s been one of the most significant changes in a long time.
via SMH